| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | 14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group. | J Clin Oncol | 2005 | 1.14 |
| 2 | Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC. | Lung Cancer | 2011 | 1.04 |
| 3 | Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer. | J Transl Med | 2010 | 1.02 |
| 4 | Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients. | Clin Lung Cancer | 2003 | 0.99 |
| 5 | Determinants of response and resistance to cytotoxics. | Semin Oncol | 2002 | 0.75 |